MedPath

RED EYE WORKPLACE

RED EYE WORKPLACE

Approved
DIN Number

02518228

Drug Class

Human

Market Date

Mar 15, 2022

Company
HC

johnson & johnson inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02518228
AIG Number0227167001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01GA52 TETRYZOLINE, COMBINATIONS
Product Specifications
Dosage FormDrops
Route of AdministrationOphthalmic
AHFS Classification52:32.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

POLYETHYLENE GLYCOL 400Active
Strength: 1 % / V/V
Monograph: POLYETHYLENE GLYCOL 400
TETRAHYDROZOLINE HYDROCHLORIDEActive
Strength: 0.05 % / W/V
Monograph: TETRAHYDROZOLINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.